When undertaking due diligence of an Food and Drug Administration (FDA)-regulated company, several pertinent questions must be asked. These inquiries ideally encompass key regulatory, compliance, and privacy-related aspects. As these sectors are critical in determining the suitability and viability of a potential acquisition or partnership, professionals operating both in law firms and large corporations should be aware of them. As written by Gardner Law, these foundational questions immerse one in a broad field of legal requirements and regulations, and are necessary to establish a transaction’s legality and potential success.
Among the areas of concern, matters relating to FDA approval, Federal Trade Commission (FTC) scrutiny, prohibitions from the Anti-Kickback Statute and the False Claims Act, stipulations under the Civil Money Penalties Law (CMP Law), health service referrals regulated by Stark Law, disclosure requirements under the Sunshine Act, and data security mandated by Health Insurance Portability and Accountability Act (HIPAA) and General Data Protection Regulation (GDPR) take precedence. Moreover, potential liabilities under the Federal Tort Claims Act (FTCA), as well as specific state regulations should also be considered.
Striking the right balance in this complex milieu is akin to finding the ‘Goldilocks Zone’ of regulatory, compliance, and privacy due diligence. Too much caution can stifle innovation and growth, while a lackadaisical approach can lead to costly legal disputes and reputational damage. Delineating a clearly defined, yet flexible strategy, and diligently adhering to it, is likely to lead to better outcomes for organizations navigating these sectors.
As law professionals, finding your own ‘Goldilocks Zone’ not only requires a comprehensive understanding of the regulatory landscape, but also a sharp instinct for assessing risk and the ability to balance corporate ambitions with legal responsibilities. Ultimately, the success of any venture within FDA-regulated sectors is as much a testament to impeccable due diligence practices as it is to innovative products, services, or solutions.